Ftse Mib
37.100,33
1,42%
DAX
21.902,42
1,63%
S&P 500
6.083,57
0,36%
NASDAQ
19.791,99
0,51%
Bitcoin
96.800,00
0,19%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Acadia Pharmaceuticals Inc (ACAD) Acadia Pharmaceuticals Inc (ACAD) Notizie

Acadia Pharmaceuticals Inc

ACAD
19,13
-0,47 (-2,40%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:54:48
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/1/202522:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
14/1/202515:05BWAcadia Pharmaceuticals Provides Business and Pipeline..
30/12/202423:37PRNUSAcadia Pharmaceuticals Set to Join S&P SmallCap 600
19/12/202422:05BWAcadia Pharmaceuticals to Present at the 43rd Annual J.P...
16/12/202422:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
11/12/202422:22EDGAR2Form 8-K - Current report
11/12/202422:05BWAcadia Pharmaceuticals Announces Closing of Sale of Rare..
11/12/202400:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202400:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/12/202415:00BWAcadia Pharmaceuticals Appoints Thomas Garner Chief..
26/11/202422:05BWAcadia Pharmaceuticals Announces Exclusive License Agreement..
21/11/202422:05BWAcadia Pharmaceuticals to Participate at Upcoming Investor..
20/11/202422:30EDGAR2Form 8-K - Current report
20/11/202402:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202402:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202402:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202422:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
14/11/202412:48EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
06/11/202422:14EDGAR2Form 8-K - Current report
06/11/202422:05BWAcadia Pharmaceuticals Reports Third Quarter 2024 Financial..
05/11/202422:05BWAcadia Pharmaceuticals Enters Into an Agreement to Sell its..
18/10/202400:41BWAcadia Pharmaceuticals to Announce Third Quarter Financial..
16/10/202422:07BWAcadia Pharmaceuticals Announces Health Canada Approval of..
16/10/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/10/202422:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
26/9/202422:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
26/9/202400:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202400:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/9/202423:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/9/202422:34EDGAR2Form 8-K - Current report
23/9/202422:15BWCatherine Owen Adams Succeeds Steve Davis as CEO of Acadia..
28/8/202422:05BWAcadia Pharmaceuticals to Participate at Upcoming Investor..
21/8/202400:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202400:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202422:39EDGAR2Form S-8 POS - Securities to be offered to employees in..
20/8/202422:37EDGAR2Form S-8 POS - Securities to be offered to employees in..
20/8/202422:35EDGAR2Form S-8 POS - Securities to be offered to employees in..
20/8/202422:33EDGAR2Form S-8 POS - Securities to be offered to employees in..
20/8/202422:31EDGAR2Form S-8 POS - Securities to be offered to employees in..
20/8/202422:29EDGAR2Form S-8 POS - Securities to be offered to employees in..
20/8/202422:27EDGAR2Form S-8 POS - Securities to be offered to employees in..
20/8/202422:25EDGAR2Form S-8 POS - Securities to be offered to employees in..
20/8/202422:23EDGAR2Form S-8 POS - Securities to be offered to employees in..
14/8/202414:04BWRyan Reynolds Announces More to Parkinson’s® Campaign
14/8/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202422:30BWAcadia Pharmaceuticals to Participate in the Canaccord..
06/8/202422:13EDGAR2Form 8-K - Current report
06/8/202422:05BWAcadia Pharmaceuticals Reports Second Quarter 2024 Financial..
24/7/202422:05BWAcadia Pharmaceuticals to Announce Second Quarter Financial..
Apertura: 19,70 Min: 19,09 Max: 19,70
Chiusura: 19,60

La tua Cronologia

NASDAQ
ACAD
Acadia Pharmaceuticals
BIT
S31883
Societe Generale Effekten
LSE
XSX6
Xstoxeu600
BIT
1AAL
American Airlines
AQSE
PNIX
Phoenix Digital Assets
AQSE
PXS.GB
Provexis
NYSE
NAC
Nuveen California Qualit...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci